HIMS: Hims & Hers Health, Inc. Stock

by  •  • Comments Off on HIMS: Hims & Hers Health, Inc. Stock

SIC 8011 – Offices and Clinics of Doctors of Medicine

Valuation
Market Cap ($M) 4,993.78
Enterprise Value ($M) 4,888.54
Book Value ($M) 344.48
Book Value / Share 1.60
Price / Book 14.50
NCAV ($M) 158.11
NCAV / Share 0.74
Price / NCAV 31.58

Profitability (mra)
Return on Invested Capital (ROIC) -0.01
Return on Assets (ROA) -0.01
Return on Equity (ROE) -0.01

Liquidity (mrq)
Quick Ratio 2.48
Current Ratio 2.80

Balance Sheet (mrq) ($M)
Current Assets 261.73
Assets 448.11
Liabilities 103.62
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 872.00
Operating Income -26.44
Net Income -23.55
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 73.48
Cash from Investing -12.11
Cash from Financing -11.47

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-22 13D/A Institutional Venture Management XVI, LLC 3.60 -41.71
02-14 13G/A Abraham Jack 4.60 -21.93
02-13 13G/A Vanguard Group Inc 6.96 25.20
01-31 13G BlackRock Inc. 5.30

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO
2024-02-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI
2023-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT
2023-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO S

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-07-26 2,448,906 10,906,548 22.45
2024-07-25 1,275,238 7,202,779 17.70
2024-07-24 1,052,929 5,396,980 19.51
2024-07-23 2,097,179 8,756,977 23.95
2024-07-22 828,681 6,162,748 13.45

(click for more detail)

Similar Companies
TDOC – Teladoc Health, Inc.


Financial data and stock pages provided by
Fintel.io